A SARS-CoV-2 Nanobody Displayed on the Surface of Human Ferritin with High Neutralization Activity
Wenrong Zhang,Haining Wang,Tong Wu,Xintao Gao,Yuting Shang,Zhifang Zhang,Xingjian Liu,Yinü Li
DOI: https://doi.org/10.2147/ijn.s450829
IF: 7.033
2024-03-09
International Journal of Nanomedicine
Abstract:Wenrong Zhang, 1, 2, &ast Haining Wang, 1, &ast Tong Wu, 1 Xintao Gao, 1 Yuting Shang, 1 Zhifang Zhang, 1 Xingjian Liu, 1 Yinü Li 1 1 National Key Laboratory of Agricultural Microbiology, Biotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing, People's Republic of China; 2 College of Life Sciences, Capital Normal University, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xingjian Liu; Yinü Li, Tel/Fax +861082109854 ; +861082105495, Email ; Purpose: COVID-19 is rampant throughout the world, which has caused great damage to human lives and seriously hindered the development of the global economy. Aiming at the treatment of SARS-CoV-2, in this study, we proposed a novel fenobody strategy based on ferritin (Fe) self-assembly technology. Methods: The neutralizing nanobody H11-D4 of SARS-CoV-2 fused to the C-terminus of end-modified human ferritin was expressed in E. coli and silkworm baculovirus expression systems. A large number of nanoparticles were successfully self-assembled in silkworms, while relatively few nanoparticles can be observed in the treated products from E. coli by electron microscopy. Subsequently, the fenobody's expression level and neutralizing activity were then evaluated. Results: The results showed that the IC 50 of H11-D4 and fenobody Fe-H11-D4 expressed in E. coli were 171.1 nmol L − 1 and 20.87 nmol L − 1 , respectively. However, the IC 50 of Fe-HD11-D4 expressed in silkworms was 1.46 nmol L − 1 showing better neutralization activity. Conclusion: Therefore, fenobodies can be well self-assembled in silkworm baculovirus expression system, and ferritin self-assembly technology can effectively improve nanobody neutralization activity. Keywords: COVID-19, ferritin, fenobody, baculovirus expression system, silkworm Since 2020, novel coronavirus disease (COVID-19) caused by SARS-CoV-2 has broken out in the world. It is very important to develop a new and effective antibody to cope with the COVID-19 pandemic. SARS-CoV-2 viruses are particles approximately 80–120 nanometres in diameter, and the presence of spikes on the surface is a distinguishing feature of this virus as a member of the Coronaviridae family. 1 The receptor-binding domain RBD of S protein on the surface of the SARS-CoV-2 virus binds to the receptor ACE2 on the body's cell membrane, allowing the virus to enter the body. 2 At present, the control strategy of SARS-CoV-2 mainly depends on the vaccine and antibody against spike (S) protein. Various vaccines have been put on the market, including inactivated vaccines, vector vaccines, recombinant sub-vaccine, etc. The antibody is another very important research strategy and has a broad research prospect. The research of antibodies has evolved from conventional antibodies to single-chain antibodies to nanobodies, and nanobodies are becoming an emerging hot field in antibody development with widespread and sustained attention due to their unique physical and chemical stability and greater suitability for large-scale production. 3 Nanobodies were first proposed in 1993 with the discovery of the variable domain of heavy chain (VHH) alone expression of a heavy chain antibody from camelid bodies 4 had a stable structure and strong antigen binding ability. 5 Accumulating works indicate that the modified nanobodies have the advantages of weaker immunogenicity, stronger penetration, 6 better stability, and higher affinity, and their preparation method is simpler, which has great development potential. 7 Recently, several strategies have been used to develop nanobodies, the nanobody Ty1 8 can be expressed in large quantities in bacteria and specifically targets RBD protein, and its binding to RBD directly blocks the binding between RBD and ACE2. The RBD-binding nanobody H11 was identified in the original alpaca VHH library, and the nanobody H11-D4 was proved to bind to RBD with a KD (dissociation constant) of 39±2 nmol L −1 , and then it was fused with the Fc segment of IgG protein to carry out the pseudovirus neutralization experiment at the cell level. The results showed that the IC 50 of H11-D4-Fc was 161 nmol L −1 . This undoubtedly provides an effective anti-COVID-19 method and an excellent candidate drug for the treatment and prevention of COVID-19. 9 Ferritin can be used as the backbone of nanoparticles because of its advantages in protein display and antigen presentation, and it -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology